Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,217
Closed -$1.76M 354
2018
Q3
$1.76M Sell
7,217
-2,710
-27% -$627K 0.38% 108
2018
Q2
$1.85M Sell
9,927
-2,302
-19% -$383K 0.42% 57
2018
Q1
$1.5M Sell
12,229
-7,426
-38% -$907K 0.37% 121
2017
Q4
$2.34M Sell
19,655
-377
-2% -$41.5K 0.58% 52
2017
Q3
$1.91M Buy
+20,032
New +$1.93M 0.37% 154
2016
Q1
Sell
-1,036
Closed -$42K 122
2015
Q4
$42K Buy
+1,036
New +$43.8K 0.34% 70

Other funds holding INGN

361 Capital's INGN Position: Q4 2018 in Review

361 Capital sold out of Inogen (INGN) in Q4 2018, closing a stake of 7,217 shares — an estimated $1.76M sold.

361 Capital first reported a position in INGN in Q4 2015 and held it in 6 quarters. The position peaked at $2.34M in Q4 2017. 271 funds tracked by Wall St. Rank hold INGN as of Q4 2018.

  • 361 Capital reported no remaining Inogen position as of Q4 2018 after selling out during the quarter.
  • 361 Capital sold 7,217 Inogen shares in Q4 2018, an estimated $1.76M.
  • 361 Capital first reported a position in Inogen in Q4 2015 and held it in 6 quarters.
  • 361 Capital's Inogen position peaked at $2.34M in Q4 2017.
  • 271 funds tracked by Wall St. Rank held Inogen as of Q4 2018.

Based on 361 Capital's 13F filing for Q4 2018, filed 8 Feb 2019.